Skip to main content
SpringerLink
Log in

Diffuse alveolar damage in nonresolving ARDS provides support for prolonged glucocorticoid treatment

  • Correspondence
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Guerin C, Bayle F, Leray V, Debord S, Stoian A, Yonis H, Roudaut JB, Bourdin G, Devouassoux-Shisheboran M, Bucher E, Ayzac L, Lantuejoul S, Philipponnet C, Kemeny JL, Souweine B, Richard JC (2015) Open lung biopsy in nonresolving ARDS frequently identifies diffuse alveolar damage regardless of the severity stage and may have implications for patient management. Intensive Care Med 41:222–230. doi:10.1007/s00134-014-3583-2

    Article  PubMed  Google Scholar 

  2. Thille AW, Esteban A, Fernandez-Segoviano P, Rodriguez JM, Aramburu JA, Vargas-Errazuriz P, Martin-Pellicer A, Lorente JA, Frutos-Vivar F (2013) Chronology of histological lesions in acute respiratory distress syndrome with diffuse alveolar damage: a prospective cohort study of clinical autopsies. Lancet Respir Med 1:395–401

    Article  PubMed  Google Scholar 

  3. Meduri GU, Eltorky MA (2015) Understanding ARDS-associated fibroproliferation. Intensive Care Med 41:517–520

    Article  PubMed  Google Scholar 

  4. Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, Thompson BT, Ancukiewicz M (2006) Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 354:1671–1684

    Article  CAS  PubMed  Google Scholar 

  5. Meduri GU, Annane D, Chrousos GP, Marik PE, Sinclair SE (2009) Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy. Chest 136:1631–1643

    Article  PubMed  Google Scholar 

  6. Wang XQ, Zhou X, Zhou Y, Rong L, Gao L, Xu W (2008) Low-dose dexamethasone alleviates lipopolysaccharide-induced acute lung injury in rats and upregulates pulmonary glucocorticoid receptors. Respirology 13:772–780

    Article  PubMed  Google Scholar 

  7. Meduri GU, Tolley EA, Chrousos GP, Stentz F (2002) Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome. Evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids. Am J Respir Crit Care Med 165:983–991

    Article  PubMed  Google Scholar 

  8. Tang B, Craig J, Eslick G, Seppelt I, McLean A (2009) Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med 37:1594–1603

    Article  CAS  PubMed  Google Scholar 

  9. Thompson BT, Ancukiewicz M, Hudson LD, Steinberg KP, Bernard GR (2007) Steroid treatment for persistent ARDS: a word of caution. Crit Care 11:425

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

This material is the result of work supported with the resources and use of facilities at the Memphis VA Medical Center. The contents of this commentary do not represent the views of the U.S. Department of Veterans Affairs or the United States Government.

Conflicts of interest

The author declares no conflicts of interest.

Author information

Authors and Affiliations

  1. Division of Pulmonary, Critical Care, and Sleep Medicine, Departments of Medicine, Memphis Veterans Affairs Medical Center, Memphis, TN, USA

    Gianfranco Umberto Meduri

Authors
  1. Gianfranco Umberto Meduri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gianfranco Umberto Meduri.

Additional information

A response to these comments can be found at: doi:10.1007/s00134-015-3813-2.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Meduri, G.U. Diffuse alveolar damage in nonresolving ARDS provides support for prolonged glucocorticoid treatment. Intensive Care Med 41, 1164–1165 (2015). https://doi.org/10.1007/s00134-015-3797-y

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-015-3797-y

Keywords

Search

Navigation